Friday 6 November 2026
Export OMCL’s income statement to Excel — free account
Omnicell, Inc.
OMCL Healthcare Health Information Services
Omnicell, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 6.53% from fiscal 2024.
- Revenue
- −0.89%
- EPS
- +100.0%
- Free cash flow
- +42.6%
- Total debt
- +0.73%
Quarter to September 2026, against a year earlier
37.33
0.70
−1.84%
Follow OMCL
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 8 | 8 | 8 |
| 0.17% | 1.63% | 3.06% | 3.52% | ||
| 0.10% | 0.98% | 1.89% | 2.23% | ||
ROIC |
0.27% | 1.77% | 3.10% | 3.45% | |
Return on Tangible Assets |
0.63% | 5.66% | 9.53% | 10.28% | |
Average Days of Receivables |
66.80 | 74.43 | 66.47 | 69.26 | |
Free Cash Flow per Share |
1.51 | 2.16 | 2.78 | 2.89 | |
Free Cash Flow |
69.37 | 97.82 | 126.77 | 132.73 | |
Capital Expenditures |
(57.93) | (58.06) | (54.67) | (53.49) | |
| Other line items | |||||
Cash ROIC |
4.35% | 5.88% | 7.24% | 7.37% | |
Accounts Receivable Turnover |
5.01 | 4.89 | 5.42 | 5.16 | |
Accounts Payable Turnover |
14.23 | 12.40 | 12.27 | 11.07 | |
Inventory Turnover |
7.19 | 7.27 | 6.80 | 6.64 | |
Average Days of Payables |
23.56 | 30.77 | 26.39 | 32.53 | |
Days of Inventory on Hand |
54.05 | 52.31 | 51.27 | 52.56 | |
Tax Rate |
(0.82) | (0.46) | (0.36) | (0.34) | |
Research and Development Expense of Revenue |
7.48% | 7.32% | 7.09% | 6.97% | |
Selling, General and Administrative Expense of Revenue |
34.57% | 33.43% | 33.03% | 32.97% | |
Share Based Compensation of Revenue |
3.76% | 3.53% | 3.60% | 3.63% | |
Interest Coverage |
— | — | 7.69 | — | |
Operating CF/Net income |
62.04 | 7.63 | 4.64 | 4.17 | |
Depreciation/Fixed assets |
0.74 | 0.72 | 0.71 | 0.69 | |
Capex/Depreciation |
(0.65) | (0.66) | (0.63) | (0.63) | |
Revenue per Share |
25.78 | 27.03 | 27.33 | 27.10 | |
Operating CF per Share |
2.77 | 3.44 | 3.98 | 4.06 | |
Capex per Share |
(1.26) | (1.28) | (1.20) | (1.17) | |
Capex to Sales |
0.05 | 0.05 | 0.04 | 0.04 |
Columns are period end dates · fundamentals updated 6 Nov 2026